Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Algernon Pharmaceuticalsinc (AGN.CN)

Algernon Pharmaceuticalsinc (AGN.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Leading DMT Companies to Take Stage at Molecular Masterclass: DMT Conference

Get a free ticket to the event here:

ENBI.CN : 0.300 (+3.45%)
ENTBF : 0.2350 (+3.52%)
DMT.VN : 0.350 (-2.78%)
AGN.CN : 0.090 (+5.88%)
Algernon Pharmaceuticals Announces Small Cell Lung Cancer Ifenprodil Research Program and Appoints Dr. William North as Lead Consultant

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the "Company" or "Algernon") a clinical stage pharmaceutical development company, is pleased to announce that it has initiated...

AGN.CN : 0.090 (+5.88%)
AGNPF : 0.0734 (+1.80%)
Algernon Pharmaceuticals Announces Exclusive Licensing Agreement with Dartmouth College

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the "Company" or "Algernon") a clinical stage pharmaceutical development company, is pleased to announce that it has signed an...

AGN.CN : 0.090 (+5.88%)
AGNPF : 0.0734 (+1.80%)
Microdose Is Pleased to Announce the DMT Conference: A Molecular Masterclass

Get a free ticket to the event here:

ENBI.CN : 0.300 (+3.45%)
ENTBF : 0.2350 (+3.52%)
AGN.CN : 0.090 (+5.88%)
Algernon Pharmaceuticals Announces 70% Enrollment of its Ifenprodil IPF and Chronic Cough Phase 2 Human Study

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: AGNPF) (the "Company" or "Algernon"), a clinical stage pharmaceutical development company, announces that it has reached 70% of its enrollment...

AGN.CN : 0.090 (+5.88%)
AGNPF : 0.0734 (+1.80%)
Algernon Pharmaceuticals Announces it Will Not Advance Ifenprodil into Phase 3 Trial for COVID-19

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the "Company" or "Algernon") a clinical stage pharmaceutical development company, announces that it will not be advancing Ifenprodil...

AGN.CN : 0.090 (+5.88%)
AGNPF : 0.0734 (+1.80%)
Algernon Pharmaceuticals Targets First Human Study of its Psychedelic Drug DMT Stroke Program for Q4, 2021

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the "Company" or "Algernon") is pleased to announce that all of the required permits and licenses for the manufacture of its cGMP...

AGN.CN : 0.090 (+5.88%)
AGNPF : 0.0734 (+1.80%)
Algernon Pharmaceuticals Launches Pancreatic Cancer Clinical Research Program with Ifenprodil

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the "Company" or "Algernon") announces it has initiated a new clinical research program for pancreatic cancer (PC) and NP-120 (Ifenprodil)....

AGN.CN : 0.090 (+5.88%)
AGNPF : 0.0734 (+1.80%)
Algernon Pharmaceuticals Highlights New Animal Study Showing Effectiveness of Psychedelic Drug DMT in Treatment of Stroke

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the "Company" or "Algernon") is pleased to highlight an independent research study from the University of Szeged in Hungary describing...

AGN.CN : 0.090 (+5.88%)
AGNPF : 0.0734 (+1.80%)
Algernon Pharmaceuticals Receives Positive Feedback from U.S. FDA for Psychedelic Drug DMT Clinical Research Program for Stroke

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the "Company" or "Algernon") announces it has received positive feedback from the U.S. Food and Drug Administration (FDA) regarding...

AGN.CN : 0.090 (+5.88%)
AGNPF : 0.0734 (+1.80%)

Barchart Exclusives

Cryptocurrencies Sink in Reaction to Evergrande Group’s Debt Crisis
Bitcoin (^BTCUSD ) is down more than -2% today at a 1-1/2 month low, adding to Monday’s -8% plunge. Also, Ethereum (^ETHUSD ) is down more than -1% today on top of Monday’s -10% plunge to a 6-week low. Cryptocurrencies have tumbled this week as they succumbed to Monday’s sell-off... Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar